Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

45.77
Delayed Data
As of Sep 19
 -1.06 / -2.26%
Today’s Change
26.26
Today|||52-Week Range
63.73
+66.86%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Kaye Edward M
Sale9/22/201640,179$60.00$2.4M-24.93%
Ingram Douglas S
President & Chief Executive Officer
Buy7/27/201747,058$42.50$2.0M+12.79%
Mahatme Sandesh
Chief Financial Officer & Senior Vice President
Sale10/17/201630,000$50.08$1.5M-6.48%
Mahatme Sandesh
CFO, CBO & Executive Vice President
Sale7/20/201732,998$41.00$1.4M+11.83%
Howton David Tyronne Jr
General Counsel & Senior Vice President
Sale7/20/201719,056$41.00$781.3K+11.83%
Kaye Edward M
Director
Sale8/03/201716,703$37.88$632.7K+20.83%
Mahatme Sandesh
CFO, CBO & Executive Vice President
Buy7/20/201732,998$13.90$458.7K+11.83%
Ruff Shamim
Sale9/22/20167,311$60.00$438.7K-24.93%
Howton David Tyronne Jr
General Counsel & Senior Vice President
Sale9/22/20167,000$60.00$420.0K-24.93%
Mahatme Sandesh
Chief Financial Officer & Senior Vice President
Buy10/17/201630,000$13.90$417.0K-6.48%
Page of 6